The Carlyle Group Inc. - Common Stock (CG)
45.06
-3.21 (-6.65%)
The Carlyle Group is a global investment firm that specializes in various asset classes, including private equity, real estate, and credit
The company connects capital from investors with opportunities across a diverse range of industries and geographies, focusing on generating value through strategic investments and active management. With a strong emphasis on relationships, Carlyle collaborates with portfolio companies to enhance their growth prospects and operational efficiency, ultimately aiming to deliver attractive returns for its investors while maintaining a commitment to responsible investment practices.

bluebird bio, Inc. (NASDAQBLUE) (“bluebird”) today announced that it has entered into a definitive agreement to be acquired by funds managed by global investment firms Carlyle NASDAQ: CGNASDAQCG)
By bluebird bio, Inc. · Via Business Wire · February 21, 2025

Industry experts join board of seasoned advisors offering strategic counsel on healthcare trends and policy for the company and its portfolio of state, federal, and commercial clients
By Acentra Health · Via GlobeNewswire · February 4, 2025

Vantive builds on a 70-year legacy of kidney care leadership and innovation, with a singular focus on empowering patients and care teams with more flexible, collaborative and accessible care options
By Vantive · Via GlobeNewswire · February 3, 2025

Industry changemaker to drive transformation and operational improvements in the development and delivery of the company’s healthcare products, solutions, and services
By Acentra Health · Via GlobeNewswire · January 23, 2025

PHOENIX, ARIZONA / ACCESS Newswire / January 17, 2025 / Copia Power ("Copia") today announced the execution of two Power Purchase Agreements ("PPAs") with Arizona Public Service Company ("APS") for Phase I and Phase II of the Maricopa Energy Center project ("Maricopa"), a 550 MW solar energy generating facility and 2,200 MWh battery energy storage facility located in Maricopa County, AZ. The project is scheduled to reach commercial operation in multiple phases between 2026-2027. Once operational, Maricopa will be the single-largest solar and energy storage project in Arizona.
Via ACCESS Newswire · January 17, 2025

Consecutive accreditations from URAC spanning 24 years underscore the company’s unwavering compliance with rigorous standards for independent medical reviews
By Acentra Health · Via GlobeNewswire · December 5, 2024

TJC LP (“TJC” or “the Firm”), a middle-market private equity firm investing primarily in North American businesses, today announced the close of its second continuation fund (the “Continuation Fund”) at $2.1 billion, which will be an extension of The Resolute Fund III, L.P. (“Resolute III”) and include an asset jointly owned with The Resolute Fund IV, L.P. (“Resolute IV”).
By TJC LP · Via Business Wire · October 1, 2024

Adherence to rigorous certification standards reinforces Acentra Health’s client-first commitment to delivering maximum value and impact with high quality solutions and services
By Acentra Health · Via GlobeNewswire · September 26, 2024

The Invesco Global Listed Private Equity ETF is a way to indirectly access private equity investments without specialized credentials.
Via MarketBeat · September 11, 2024

Advance Auto Parts streamlines its business and confronts economic headwinds with strategic initiatives to drive future growth.
Via MarketBeat · August 22, 2024

Baxter International Inc. (NYSEBAX), a global medtech leader, and funds managed by global investment firm Carlyle NASDAQ:CGNASDAQCG)
By Baxter International Inc. · Via Business Wire · August 13, 2024

Cogentrix Platform Consists of 11 Natural Gas-Fired Power Plants, Comprising 5.3 Gigawatts of Efficient and Reliable Capacity Across Key U.S. Markets
By Quantum Capital Group · Via GlobeNewswire · August 5, 2024

MCLEAN, Va., July 23, 2024 (GLOBE NEWSWIRE) -- Acentra Health, a technology solutions and clinical services company dedicated to helping government healthcare agencies accelerate better health outcomes, has named Brett Barton as Senior Vice President (SVP) of Client Experience. In this newly created role, Barton will represent the voice of the client across multiple touchpoints to deliver an exceptional experience that supports continued growth for the company and elevates the Acentra Health brand.
By Acentra Health · Via GlobeNewswire · July 23, 2024

By KKR · Via Business Wire · July 17, 2024

Bosch will oversee the company's work to accelerate the delivery of clinically evidenced solutions that improve health outcomes and advance health equity at scale
By Acentra Health · Via GlobeNewswire · July 16, 2024

MCLEAN, Va., June 18, 2024 (GLOBE NEWSWIRE) -- Acentra Health, a technology solutions and clinical services company dedicated to helping government healthcare agencies accelerate better health outcomes, today announced that Heather Adamson has joined the company as Senior Vice President of Marketing. In this role, Adamson will oversee the development and implementation of the company’s marketing strategy, creating data-driven frameworks to support the company’s brand, content, digital, and product marketing programs. She reports to Acentra Health’s Chief Growth Officer.
By Acentra Health · Via GlobeNewswire · June 18, 2024

Multi-phase demonstration is first in the U.S. to introduce Medicaid funding for interventions that address health outcomes related to social needs
By Acentra Health · Via GlobeNewswire · June 13, 2024

MCLEAN, Va., June 11, 2024 (GLOBE NEWSWIRE) -- Acentra Health, a technology solutions and clinical services company dedicated to helping government healthcare agencies accelerate better health outcomes, is the winner of the Association of Corporate Growth (ACG) National Capital chapter’s Corporate Growth Award for companies over $250 million in annual revenue. ACG’s growth awards honor the Washington D.C., region’s fastest growing companies and business leaders whose deals created significant corporate value in 2023 through mergers and acquisitions, strategic partnerships, organic growth, and capital financing.
By Acentra Health · Via GlobeNewswire · June 11, 2024

MCLEAN, Va., May 02, 2024 (GLOBE NEWSWIRE) -- Acentra Health, a Virginia-based technology solutions and clinical services company dedicated to helping government healthcare agencies accelerate better health outcomes, announced today that Acentra Health Executive Vice President and Chief Strategy Officer Verlon Johnson, MPA, has been appointed Chair of the Medicaid and CHIP Payment and Access Commission (MACPAC) by the U.S. Government Accountability Office (GAO). In addition, she was reappointed to serve a second consecutive three-year term as a MACPAC commissioner.
By Acentra Health · Via GlobeNewswire · May 2, 2024

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) and Launch Therapeutics, Inc., today announced a clinical collaboration agreement to further accelerate the clinical research program of Teva’s ICS-SABA (TEV-‘248). Teva and Abingworth, a leading international life sciences investment group, part of global investment firm Carlyle (NASDAQCG), today also announced a strategic development funding agreement in which Abingworth provides Teva up to $150 million to offset Teva’s ICS/SABA (TEV-‘248) program costs.
By Teva Pharmaceutical Industries Limited · Via Business Wire · April 1, 2024

MCLEAN, Va., March 26, 2024 (GLOBE NEWSWIRE) -- Acentra Health, a Virginia-based technology solutions and clinical services company dedicated to helping government healthcare agencies accelerate better health outcomes, announced the appointment of Grant Christie as Senior Vice President, Market Strategy and Solutions. A seasoned information technology solutions and services veteran with extensive experience in the public sector and commercial healthcare spaces, Christie will play a pivotal role in aligning Acentra Health’s portfolio of products, solutions, and tech-enabled services to meet the needs and demands of the healthcare market and promote continued strong growth for the company.
By Acentra Health · Via GlobeNewswire · March 26, 2024

SER (the “Company”), a leading global Intelligent Content Automation (“ICA”) software vendor in the Enterprise Content Management (“ECM”) market, today announced that TA Associates (“TA”), a leading global private equity firm, has agreed to make a strategic growth investment in the Company. SER and Carlyle, an investor in SER since 2018, welcome TA as the new lead investor.
By SER · Via Business Wire · March 21, 2024

MCLEAN, Va., Jan. 31, 2024 (GLOBE NEWSWIRE) -- Acentra Health, a Virginia-based technology services and solutions company dedicated to helping government healthcare agencies accelerate better health outcomes, announced the appointment of Daniel Hallenbeck as Vice President (VP) of Strategy and Strategic Partnerships. A nationally recognized expert in Medicaid Enterprise Systems and a former New York State (NYS) Medicaid Chief Technology Officer (CTO), Hallenbeck will serve as an integral member of the Acentra Health Leadership Team, supporting the Chief Strategy Officer in the development and execution of the company’s strategy around value creation, digital health, and mergers and acquisitions.
By Acentra Health · Via GlobeNewswire · January 31, 2024

Combined company to drive improvements in mental health outcomes through technology enablement, data analytics, and clinical expertise
By Acentra Health · Via GlobeNewswire · January 4, 2024

Three-year designation demonstrates company’s adherence to rigorous standards of quality and safety that drive better health outcomes
By Acentra Health · Via GlobeNewswire · December 19, 2023